London, England, United Kingdom
Commercial growth professional with 10+ years’ experience across Life Sciences, Renewable Energy, and Technology-driven sectors. My background combines strategic key account management, market expansion, and product launch execution within highly regulated and competitive industries. I have led commercial development across institutional accounts, supported national product launches, and driven revenue growth through structured stakeholder engagement and cross-functional collaboration. In renewable energy, I led business development initiatives for solar energy projects, building pipeline opportunities, negotiating contracts, and coordinating technical-commercial alignment between engineering and clients. Currently operating within Tesla’s UK national sales structure, managing portfolio growth and retention strategy across a high-value customer base. Long-term focus: scaling commercial operations across EMEA and GCC markets.
Promoted from previous role. Manage national portfolio of existing Tesla customers, driving revenue retention, upgrade strategy, and commercial conversion across UK market. Execute structured outbound campaigns to increase vehicle replacement cycles, financing upgrades, and product adoption. Collaborate with operations, delivery, and finance teams to remove commercial blockers and accelerate deal closure.
Managed EMEA aftersales customer accounts, resolving high-value escalations while protecting brand equity and revenue continuity. Identified commercial recovery opportunities contributing to upgrade and repurchase conversion initiatives. Contributed to service redesign feedback loops to improve operational efficiency and customer experience.
Led end-to-end business development for commercial and residential solar projects, from opportunity identification to contract negotiation and execution. Built and managed sales pipeline, converting technical proposals into signed EPC agreements. Developed partnerships with EPC contractors, suppliers, and corporate clients to expand market footprint. Coordinated financial modelling and project feasibility discussions to support client investment decisions. Managed special project unit launch (PWR Pod)
Managed strategic institutional accounts across KSA, driving market penetration and launch execution of Ozempic and Insulin Degludec. Developed structured account plans across hospital networks and healthcare groups. Led stakeholder engagement initiatives to accelerate product adoption in competitive therapeutic areas.
Managed insulin and growth hormone portfolios across institutional and private healthcare sectors. Executed territory expansion and account growth strategies within regulated pharmaceutical markets.
Contributed to the national launch of HCV treatment initiatives during Egypt’s large-scale hepatitis C eradication campaign. Supported institutional adoption across hospital networks within highly regulated public health programs.